Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1401
Frequency Electronics
FEIM
$847M
| $6.02M | 0.01% |
265,061
-52,500
| -17% | -$973K |
2013 Q2
48 quarters
|
|
1402
Winnebago Industries
WGO
$661M
| $6.01M | 0.01% |
207,300
+138,300
| +200% | +$4.53M |
2024 Q3
3 quarters
|
|
1403
Southern Missouri Bancorp
SMBC
$770M
| $6.01M | 0.01% |
109,634
+9,800
| +10% | +$512K |
2016 Q2
36 quarters
|
|
1404
DELISTED
iTeos Therapeutics
ITOS
| $6M | 0.01% |
602,100
-43,500
| -7% | -$350K |
2021 Q4
14 quarters
|
|
1405
Adtran
ADTN
$608M
| $6M | 0.01% |
668,840
-149,289
| -18% | -$1.19M |
2014 Q1
45 quarters
|
|
1406
Stratasys
SSYS
$699M
| $6M | 0.01% |
523,032
+16,800
| +3% | +$170K |
2020 Q2
20 quarters
|
|
1407
Novanta
NOVT
$5.34B
| $5.98M | 0.01% |
46,400
+43,400
| +1,447% | +$5.28M |
2025 Q1
1 quarter
|
|
1408
Sable Offshore Corp
SOC
$714M
| $5.98M | 0.01% |
272,000
+244,300
| +882% | +$5.68M |
2024 Q3
3 quarters
|
|
1409
Conduent
CNDT
$249M
| $5.97M | 0.01% |
2,262,700
-376,765
| -14% | -$885K |
2017 Q3
31 quarters
|
|
1410
Citigroup
C
$217B
| $5.97M | 0.01% |
70,119
-551,354
| -89% | -$39.9M |
2022 Q2
12 quarters
|
|
1411
Dime Commercial Bancshares
DCOM
$1.68B
| $5.96M | 0.01% |
221,415
+27,360
| +14% | +$716K |
2014 Q4
42 quarters
|
|
1412
dLocal
DLO
$4.48B
| $5.96M | 0.01% |
526,000
+201,989
| +62% | +$1.99M |
2025 Q1
1 quarter
|
|
1413
VanEck Intermediate Muni ETF
ITM
$2.1B
| $5.94M | 0.01% |
130,700
+34,400
| +36% | +$1.55M |
2023 Q4
6 quarters
|
|
1414
Bowhead Specialty Holdings
BOW
$1.12B
| $5.94M | 0.01% |
158,300
+7,000
| +5% | +$268K |
2024 Q3
3 quarters
|
|
1415
Steris
STE
$20.9B
| $5.94M | 0.01% |
+24,708
| New | +$5.75M |
2025 Q2
0 quarters
|
|
1416
ATN International
ATNI
$393M
| $5.91M | 0.01% |
363,832
-3,900
| -1% | -$63.5K |
2016 Q2
36 quarters
|
|
1417
iShares MSCI USA Momentum Factor ETF
MTUM
$20.5B
| $5.91M | 0.01% |
+24,600
| New | +$5.37M |
2025 Q2
0 quarters
|
|
1418
Flexsteel Industries
FLXS
$348M
| $5.91M | 0.01% |
164,073
-12,227
| -7% | -$404K |
2016 Q3
35 quarters
|
|
1419
Trimble
TRMB
$14B
| $5.91M | 0.01% |
77,744
-335,600
| -81% | -$22.5M |
2025 Q1
1 quarter
|
|
1420
iShares Intermediate Government/Credit Bond ETF
GVI
$3.74B
| $5.91M | 0.01% |
55,300
+2,500
| +5% | +$264K |
2025 Q1
1 quarter
|
|
1421
Ameris Bancorp
ABCB
$5.3B
| $5.9M | 0.01% |
91,169
+60,600
| +198% | +$3.59M |
2025 Q1
1 quarter
|
|
1422
J. Jill
JILL
$364M
| $5.89M | 0.01% |
402,300
-13,200
| -3% | -$209K |
2018 Q3
27 quarters
|
|
1423
ARK 21Shares Bitcoin ETF
ARKB
$3.14B
| $5.86M | 0.01% |
+163,800
| New | +$5.37M |
2025 Q2
0 quarters
|
|
1424
AnaptysBio
ANAB
$1.37B
| $5.84M | 0.01% |
263,086
-75,614
| -22% | -$1.58M |
2023 Q1
9 quarters
|
|
1425
CDW
CDW
$17.8B
| $5.84M | 0.01% |
+32,698
| New | +$5.55M |
2025 Q2
0 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.